AVROBIO
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AVROBIO generated cash of -$63,190,000, which is more than the previous year. Cash used in financing activities reached the amount of -$16,029,000 last year. Net change in cash is therefore $5,457,000.
Cash Flow
| 2016 | -3.31M | -24K | 8.69M |
|---|---|---|---|
| 2017 | -16.38M | -383K | 17.37M |
| 2018 | -37.64M | -1.83M | 160.28M |
| 2019 | -67.66M | -1.58M | 129.99M |
| 2020 | -98.80M | -1.17M | 172.61M |
| 2021 | -98.02M | -2.46M | 30.37M |
| 2022 | -97.20M | -267K | 262K |
| 2023 | -63.19M | 85.07M | -16.02M |
AVRO Cash Flow Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 92.84M | 190.05M | 260.17M | 187.53M | 126.79M | 5.98M | 5.35M | 0 |
Operating activities | ||||||||
Net income | 12.15M | -105.89M | -119.12M | -119.71M | -72.96M | -46.36M | -18.64M | -4.66M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 617K | 1.44M | 1.39M | 1.20M | 850K | 380K | 45K | 0 |
Stock-based compensation expense | 6.89M | 11.52M | 18.57M | 15.62M | 6.8M | 0 | 177K | 72K |
| Deferred income tax benefit | 6.89M | 11.52M | 18.57M | 15.62M | 6.8M | 0 | 177K | 72K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -357K | -3.10M | 804K | -881K | 1.02M | 2.01M | 176K | 177K |
Cash generated by operating activities | -63.19M | -97.20M | -98.02M | -98.80M | -67.66M | -37.64M | -16.38M | -3.31M |
Investing activities | ||||||||
Purchases Of Investments | -85.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -8K | -267K | -2.46M | -1.17M | -1.58M | -1.83M | -383K | 0 |
Acquisitions Net | 1.34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 85.07M | -267K | -2.46M | -1.17M | -1.58M | -1.83M | -383K | -24K |
Financing activities | ||||||||
Common Stock Issued | 321K | 262K | 15.47M | 172.18M | 129.46M | 104.01M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 86K | 0 | -205K | 166K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -14.89M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -16.02M | 262K | 30.37M | 172.61M | 129.99M | 160.28M | 17.37M | 8.69M |
Net Change In Cash | 5.45M | -97.21M | -70.11M | 72.63M | 60.74M | 120.80M | 606K | 5.35M |
Cash at end of period | 98.30M | 92.84M | 190.05M | 260.17M | 187.53M | 126.79M | 5.96M | 5.35M |
| Data source | Data source | Data source | Data source | Data source | Data source |